Alnylam
Alnylam is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Alnylam products.
Drugs from Alnylam supported via NPP
| Brand | Generic | Category | Indication |
|---|---|---|---|
| Amvuttra | vutrisiran | Neurology (hATTR) | hATTR-PN; ATTR-CM (2025) |
How NPP access to Alnylam products works
Reserve Meds sources Alnylam products from DSCSA-compliant US specialty wholesalers, not from parallel-import channels. All supply is US-FDA-provenance.
Not affiliated with Alnylam
Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Alnylam.